Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Therapeuticsmd (TXMD) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 38 quarters since 2012. Compare with TXMD stock chart to see long term trends.

TXMD stock compared to

TXMD Income Statement

Revenue, Net:23001000
Revenue Per Share:0.05
Cost of Goods & Services Sold:4132000
Gross Profit:18869000
Selling, General & Admin Expense:32164000
Research & Development Expense:2011000
Total Operating Expenses:54048000
Operating Income:-42652000
Income Taxes:0
Net Income:-42652000
Earnings Per Share, Basic:-0.11
Shares Outstanding, Basic Avg:423817326

TXMD Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:1042000
Change in Accounts Receiveable:-23000
Net Cash from Operations:-26532000
Net Cash from Financing Activities:428000
Property, Plant & Equipment Purchases:41000
Net Cash from Investing Activities:-89000
Net Change in Cash & Equivalents:-26193000

TXMD Balance Sheet

Cash and Cash Equivalents:111424000
Accounts Receivable, Net:33481000
Inventories:7574000
Total Current Assets:159657000
Property, Plant & Equipment, Net:1647000
Total Assets:210601000
Accounts Payable:14565000
Current Portion of Long-Term Debt:10000000
Total Short-Term Liabilities:75675000
Long Term Debt, Non-Current Portion:175261000
Total Liabilities:259675000

Insider Trading

Change
Value
Transaction
SEC Form 4
Collins Cooper C.   Director
1,000,000 sh at $1
$725,000
Buy
2021-08-19
Ling Karen   Director
33,445 sh at $1
$25,084
Buy
2021-08-19
BISARO PAUL   Director
50,000 sh at $1
$39,500
Buy
2021-08-18
Thompson Tommy G   Director
 
 
Buy
2021-08-17

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
24,839,967 sh
-2,757,454 sh
-10%
$29,558
-$7,423
Vanguard Group Inc
18,611,213 sh
519,864 sh
3%
$22,148
-$2,095
Price T Rowe Associates Inc /Md/
18,493,273 sh
180,286 sh
1%
$22,007
-$2,532
FMR LLC
13,897,859 sh
-8,246 sh
0%
$16,538
-$2,096
Morgan Stanley
10,203,011 sh
2,882,996 sh
39%
$12,142
$2,333
Morgan Stanley
10,203,011 sh
2,882,996 sh
39%
$12,142
$2,333
State Street Corp
9,002,353 sh
1,818,736 sh
25%
$10,713
$1,087
Ra Capital Management, L.P.
7,812,500 sh
 
$9,297
C Worldwide Group Holding A/S
6,189,834 sh
 
$7,366
Geode Capital Management, LLC
6,180,021 sh
623,917 sh
11%
$7,354
-$91
Ameriprise Financial Inc
5,970,219 sh
1,204,018 sh
25%
$7,103
$717
AXA
4,569,339 sh
-2,138,312 sh
-32%
$5,438
-$3,550
AXA
4,569,339 sh
-2,138,312 sh
-32%
$5,438
-$3,550
Nuveen Asset Management, LLC
3,962,840 sh
1,972,577 sh
99%
$4,716
$2,049
Northern Trust Corp
3,895,950 sh
179,855 sh
5%
$4,636
-$343
Bamco Inc /Ny/
3,831,500 sh
 
$4,559
Sanders Morris Harris LLC
3,440,816 sh
-81,000 sh
-2%
$4,095
-$624
Rubric Capital Management Lp
2,794,302 sh
 
$3,325
Charles Schwab Investment Management Inc
2,488,953 sh
99,443 sh
4%
$2,962
-$240
Stifel Financial Corp
2,351,620 sh
175,880 sh
8%
$2,799
-$116

Data imported from Therapeuticsmd Inc SEC filings. Check original filings before making any investment decision.

Privacy   Terms© ChartInsight LLC 2021  

All data provided without any warranty because SEC XML files are imported via an automated process. Check original SEC filings before making any investment decision.